PD-L1 in immune-escape of breast and prostate cancers: from biology to therapy

被引：15
|
作者：
Bonfiglio, Rita [1 ]
Nardozi, Daniela [1 ]
Scimeca, Manuel [1 ,2 ,3 ]
Cerroni, Chiara [1 ]
Mauriello, Alessandro [1 ]
Bonanno, Elena [1 ]
机构：
[1] Univ Tor Vergata, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy
[2] OrchideaLab Srl, Via Grecale 6, Rome, RM, Italy
[3] IRCCS San Raffaele Pisana, I-00166 Rome, Italy
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 24期
关键词：
biological therapy; breast cancer; prostate cancer; urologic cancer; EXPRESSION;
D O I：
10.2217/fon-2017-0278
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2129 / 2131
页数：3
相关论文
共 50 条
  • [1] CTC immune escape mediated by PD-L1
    Wang, Xuefei
    Sun, Qiang
    Liu, Qiaofei
    Wang, Changjun
    Yao, Ru
    Wang, Yimin
    MEDICAL HYPOTHESES, 2016, 93 : 138 - 139
  • [2] Immune Escape Mediated by Exosomal PD-L1 in Cancer
    Lawler, Sean E.
    Nowicki, Michal O.
    Ricklefs, Franz L.
    Chiocca, E. Antonio
    ADVANCED BIOSYSTEMS, 2020, 4 (12)
  • [3] Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
    Iwai, Y
    Ishida, M
    Tanaka, Y
    Okazaki, T
    Honjo, T
    Minato, N
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12293 - 12297
  • [4] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [5] PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
    Stein, Alexander
    Simnica, Donjete
    Schultheiss, Christoph
    Scholz, Rebekka
    Tintelnot, Joseph
    Goekkurt, Eray
    von Wenserski, Lisa
    Willscher, Edith
    Paschold, Lisa
    Sauer, Markus
    Lorenzen, Sylvie
    Riera-Knorrenschild, Jorge
    Depenbusch, Reinhard
    Ettrich, Thomas J.
    Doerfel, Steffen
    Al-Batran, Salah-Eddin
    Karthaus, Meinolf
    Pelzer, Uwe
    Waberer, Lisa
    Hinke, Axel
    Bauer, Marcus
    Massa, Chiara
    Seliger, Barbara
    Wickenhauser, Claudia
    Bokemeyer, Carsten
    Hegewisch-Becker, Susanna
    Binder, Mascha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [6] PD-L1 and PD-1 in immune regulation and their implications in blood cancers
    Aghbash, Parisa Shiri
    Mehdizadeh, Faezeh
    Pourbeiragh, Ghazal
    Yazdani, Yalda
    Baghi, Hossein Bannazadeh
    Sales, Abolfazl Jafari
    Pashazadeh, Mehrdad
    Kangari, Parisa
    ADVANCES IN CANCER BIOLOGY-METASTASIS, 2024, 11
  • [7] ACLY-mediated breast tumorigenesis is driven by immune escape via PD-L1 signaling
    Hegde, M.
    Kunnumakkara, A. B.
    ANNALS OF ONCOLOGY, 2022, 33 : S136 - S136
  • [8] PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors
    Kakavand, Hojabr
    Rawson, Robert V.
    Pupo, Gulietta M.
    Yang, Jean Y. H.
    Menzies, Alexander M.
    Carlino, Matteo S.
    Kefford, Richard F.
    Howle, Julie R.
    Saw, Robyn P. M.
    Thompson, John F.
    Wilmott, James S.
    Long, Georgina V.
    Scolyer, Richard A.
    Rizos, Helen
    CLINICAL CANCER RESEARCH, 2017, 23 (20) : 6054 - 6061
  • [9] Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
    Jiang, Xianjie
    Wang, Jie
    Deng, Xiangying
    Xiong, Fang
    Ge, Junshang
    Xiang, Bo
    Wu, Xu
    Ma, Jian
    Zhou, Ming
    Li, Xiaoling
    Li, Yong
    Li, Guiyuan
    Xiong, Wei
    Guo, Can
    Zeng, Zhaoyang
    MOLECULAR CANCER, 2019, 18 (1)
  • [10] Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
    Kim, J. M.
    Chen, D. S.
    ANNALS OF ONCOLOGY, 2016, 27 (08) : 1492 - 1504
12345